Exploring medication adherence in metastatic breast cancer patients
A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer
European Institute of Oncology · NCT06343181
This study is trying to understand what helps or hinders women with advanced breast cancer from sticking to their medication plans by talking to them in focus groups.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | European Institute of Oncology (other) |
| Locations | 1 site (Milan) |
| Trial ID | NCT06343181 on ClinicalTrials.gov |
What this trial studies
This qualitative observational study aims to investigate the factors influencing medication adherence among patients with metastatic breast cancer. It will involve conducting four focus groups to gather insights on barriers, resources, and psychological, clinical, and contextual factors affecting adherence to pharmacological therapy. Participants will include patients currently receiving or who have received oral oncologic therapy at the European Institute of Oncology. The study seeks to identify patient needs and preferences regarding treatment to enhance adherence.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old diagnosed with metastatic breast cancer who have access to the internet and a device for remote participation.
Not a fit: Patients with psychiatric or neurological conditions that impair their ability to participate or those with other medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for enhancing medication adherence in metastatic breast cancer patients.
How similar studies have performed: While qualitative studies on treatment adherence exist, this specific focus on metastatic breast cancer and its unique challenges is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18 years old; * Diagnosis of metastatic breast cancer; * Availability of an internet connection and a PC or Tablet (for remote focus groups); * Signing of the informed consent. Exclusion Criteria: * Presence of psychiatric or neurological conditions impairing the ability to comprehend the questions in Focus Groups or to express free consent to participate in the study; * Presence of medical or oncological conditions other than metastatic breast cancer; * Refusal to sign the informed consent.
Where this trial is running
Milan
- European Institute of Oncology — Milan, Italy (RECRUITING)
Study contacts
- Principal investigator: Gabriella Pravettoni — European Institute of Oncology
- Study coordinator: Gabriella Pravettoni
- Email: gabriella.pravettoni@ieo.it
- Phone: +390257489731
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Metastatic Breast Cancer